Perez-Belmonte, Luis MMiramontes-Gonzalez, Jose POsuna-Sanchez, JulioLara, Jose PGómez-Huelgas, Ricardo2023-05-032023-05-032022-01-29Pérez-Belmonte LM, Miramontes-González JP, Osuna-Sánchez J, Lara JP, Gómez-Huelgas R. Reply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure. J Am Geriatr Soc. 2022;70:1585-1589http://hdl.handle.net/10668/19985We greatly appreciate the comments from Ismayilovet al. 1 regarding our recent publication on the clinicalbenefits of empagliflozin in very old patients in the hospi-tal setting.enBenzhydryl CompoundsDiabetes Mellitus, Type 2GlucosidesHeart FailureBenzhydryl CompoundsDiabetes Mellitus, Type 2GlucosidesHeart FailureHumansReply to: Comment on: Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure.letter to the editor35174486Benzhydryl CompoundsDiabetes Mellitus, Type 2GlucosidesHeart FailureHumans10.1111/jgs.177031532-5415